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Abnormal dendritic complexity is a shared feature
of many neurodevelopmental disorders associated
with neurological defects. Here, we found that the
actin-crosslinking protein filamin A (FLNA) is overex-
pressed in tuberous sclerosis complex (TSC) mice, a
PI3K-mTOR model of neurodevelopmental disease
that is associated with abnormal dendritic com-
plexity. Both under- and overexpression of FLNA in
wild-type neurons led to more complex dendritic ar-
bors in vivo, suggesting that an optimal level of FLNA
expression is required for normal dendritogenesis. In
Tsc1null neurons, knocking down FLNA in vivo pre-
vented dendritic abnormalities. Surprisingly, FLNA
overexpression in Tsc1null neurons was dependent
onMEK1/2 but not mTOR activity, despite both path-
ways being hyperactive. In addition, increasingMEK-
ERK1/2 activity led to dendritic abnormalities via
FLNA, and decreasing MEK-ERK1/2 signaling in
Tsc1null neurons rescued dendritic defects. These
data demonstrate that altered FLNA expression
increases dendritic complexity and contributes to
pathologic dendritic patterning in TSC in an mTOR-
independent, ERK1/2-dependent manner.
INTRODUCTION
Dendritic arborization determines the synaptic connectivity and
input integration that are necessary for proper network function.
As such, alterations in dendritic morphology affect network
activity and stability (Ha¨usser et al., 2000; Jan and Jan, 2010;
Sjo¨stro¨m et al., 2008). Anomalies in dendritic morphology are
observed in and contribute to the pathology of many neurodeve-
lopmental and neurodegenerative disorders (Dierssen and Ram-
akers, 2006; Jan and Jan, 2010; Nestor and Hoffman, 2012). In
particular, abnormal dendritic complexity is a shared feature of
neurodevelopmental disorders associated with cognitive and
social impairments, and altered tuberous sclerosis complex-78 Neuron 84, 78–91, October 1, 2014 ª2014 Elsevier Inc.mammalian target of rapamycin (TSC-mTOR) signaling (Crino
et al., 2006; Feliciano et al., 2013a; Kwiatkowski and Manning,
2005; Kwon et al., 2006). TSC is one such neurodevelopmental
disorder. However, themolecules responsible for increased den-
dritic arborization in TSC remain elusive.
TSC is due tomutations in either TSC1 or TSC2, whose protein
products form a functional complex. The major function of the
TSC complex is to repress the activity of Ras homolog enriched
in brain (Rheb), the canonical activator of mTOR complex 1
(mTORC1). Thus, loss of Tsc1 in neurons results in hyperactive
mTORC1 and morphological changes such as increased soma
size and dendritic hypertrophy (Feliciano et al., 2011, 2012,
2013a; Meikle et al., 2007; Neuman and Henske, 2011). To iden-
tify dysregulated genes that may contribute to dendritic over-
growth in TSC, we performed a PCR array from conditional
Tsc1 knockout mouse tissue and found that the filamin A gene
(Flna) transcript was significantly elevated. Although filamin A
(FLNA) has no documented role in dendritic morphogenesis, its
well-studied role in cytoskeletal reorganization prompted us to
ask whether FLNA might also regulate dendritogenesis and
contribute to pathologic dendritic arborization in TSC.
FLNA is a scaffolding protein with actin crosslinking capacity
that couples extracellular signaling to the cellular cytoskeleton
(Nakamura et al., 2011). As a result, FLNA regulates diverse
aspects of cell development, including filopodia formation in
nonneuronal cells (Ohta et al., 1999), growth cone progression
in Drosophila (Zheng et al., 2011), proliferation of cortical neural
progenitors (Carabalona et al., 2012; Lian et al., 2012), and
migration of diverse cell types (Baldassarre et al., 2009; Cunning-
ham et al., 1992; Fox et al., 1998; Xu et al., 2010) including devel-
oping cortical neurons (Nagano et al., 2004; Sarkisian et al.,
2006, 2008). Consistent with a role in neurodevelopment, human
FLNA loss-of-function mutations result in the brain disorder X-
linked periventricular nodular heterotopia (Eksxioglu et al., 1996;
Fox et al., 1998). Despite documented roles for FLNA in cell
morphogenesis, neurite extension, and neural growth cone dy-
namics (Letourneau and Shattuck, 1989), it remains unknown
whether FLNA also regulates dendritic morphogenesis.
Here, we set out to address whether FLNA contributes to
normal dendritic patterning and pathological dendritic arboriza-
tion in TSC using combined genetic, pharmacologic, and physio-
logical approaches. We first verified our array data by confirming
Figure 1. Flna mRNA Is Increased in Tsc1null Neurons
(A) Diagram illustrating electroporation in P0 neonates. Most transfected
newborn neurons reach their final location in the OB by P14.
(B) Diagram of the experimental protocol. Electroporation of a Cre-encoding
vector in RTsc1fl/mut mice results in tdTomato expression and deletion of the
Tsc1 floxed allele.
(C) Images of the ipsilateral (ipsi) brain containing Tsc1null neurons in the
OB and contralateral (contra) brain devoid of electroporated neurons from
RTsc1fl/mut mice.
(D) Fold change (>1.5) of five transcripts in P14 ipsilateral (electroporated)
versus contralateral (unelectroporated) OB from RTsc1fl/mut mice electro-
porated with a Cre-encoding plasmid.
(E) qRT-PCR of normalized Flna/Gapdh fold-change from the ipsilateral OB
containing Tsc1null neurons (black) and from the contralateral OB (gray; n = 3
OBs each, P21, p < 0.05).
Error bars correspond to SEM.
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MEK1-Filamin A and Dendritic Hypertrophy in TSCthat FLNA levels are elevated in Tsc1null neurons. We then estab-
lished a physiological role for FLNA in normal dendritic morpho-
genesis. Next, we found that normalizing FLNA levels in Tsc1null
neurons prevented abnormal dendritic morphology. We then
sought to identify the molecular mechanism responsible for
elevated FLNA levels in TSC. Although hyperactive mTORC1
signaling is known to increase protein translation and our initial
observation was that Flna transcription is increased in Tsc1null
neurons, we were still surprised to find that FLNA expression
was resistant to mTOR blockers. Therefore, we examined
ERK1/2 because Flna transcription is predicted to be ERK1/2
dependent (D’Addario et al., 2002; 2006; Tan and Khachigian,
2009) and ERK1/2 is hyperactive in TSC individuals and mouse
models of TSC (Magri et al., 2011; Maldonado et al., 2003). We
found that a MEK-ERK1/2-dependent increase in FLNA levels
contributes to pathological dendritic complexity in TSC. In addi-
tion, blocking MEK-ERK1/2 activity in Tsc1null neurons after den-
dritic defects have been established is sufficient to rescue the
dendritic phenotype. Collectively, our findings identify FLNA as
a player in dendritic morphogenesis and uncover an mTORC1-
independent, ERK1/2-dependent increase in FLNA downstream
of TSC1/TSC2 signaling that contributes to dendritic anomaliesin Tsc1null neurons. Because mTORC1 inhibition can partially
rescue dendritic pathology without rescuing FLNA levels,
we propose that elevated MEK-ERK1/2-FLNA and hyperactive
mTORC1 independently contribute to dendritic anomalies in TSC.
RESULTS
Identification of Elevated FlnamRNA in Tsc1null Neurons
To identify genes whose altered expression might contribute to
morphological dysfunction in disorders of the TSC-mTORC1
signaling pathway, we used a quantitative RT-PCR (qRT-PCR)
array to assess the levels of 84 neurogenesis genes in Tsc1null
neuron-containing olfactory bulbs (OBs). To generate Tsc1null
neurons in the OBs, we exploited the fact that neural stem cells
located in the subventricular zone (SVZ) along the lateral ventricle
generate OB neurons postnatally that are easily electroporated
neonatally (Boutin et al., 2008; Lacar et al., 2010; Platel et al.,
2010). We electroporated a Cre recombinase-encoding plasmid
(Cre) at postnatal day (P) 0 into SVZ neural stem cells of Tsc1fl/mut
mice (fl, floxed; mut, mutant, loss-of-function mutation) crossed
with tdTomato reporter mice (R26RtdTomato/Tsc1fl/mut mice
abbreviated RTsc1fl/mut mice) (Figures 1A and 1B; Table S1 avail-
able online for a list of plasmids). In these mice, Cre electropora-
tion led to tdTomato expression and excision of the floxed Tsc1
allele in both neural stem cells and their progeny, as we have pre-
viously reported (Feliciano et al., 2012; data not shown). We used
Tsc1fl/mut mice to match the genetics of TSC individuals who are
heterozygous for one of the TSC alleles (TSC1 or TSC2) but har-
bor neurons that lose the second TSC allele during development
(Au et al., 2004; Feliciano et al., 2013a; Kwiatkowski and Short,
1994). As a control, we used the contralateral OB that does not
contain electroporated cells.
We performed a qRT-PCR array on messenger RNA (mRNA)
from electroporated (ipsilateral) P14 OBs and from contralateral
(control) OBs (n = 2 mice per condition; Figure 1C). Of the 84
genes in the array, we found that the mRNA of 5 genes (Alk,
Drd5, Flna, Bmp8b, and Gdnf) were upregulated by >1.5-fold in
both Tsc1null samples compared to control samples while several
mRNAs were downregulated (Figure 1D and Table S2). We
focused on the actin crosslinking protein FLNA because of its
proposed role in neurite morphogenesis. We confirmed the in-
crease in Flna gene expression by qRT-PCR of Flna mRNA
from the OBs containing Tsc1null neurons and the contralateral
unelectroporated Tsc1fl/mut OBs (Figure 1E). Using Gapdh as a
control, we found that Flna mRNA levels were 4-fold higher in
the OBs containing Tsc1null neurons compared to the control
OBs (n = 3 mice, p < 0.05, Student’s t test; Figure 1E).
Tsc1 Deletion and Hyperactive Rheb Increase
FLNA Protein Expression
To determine whether increased Flna mRNA leads to increased
FLNA protein expression, we immunoblotted for FLNA in three
different systems: conditional Tsc1 knockout mice, cell culture,
and tissue from human TSC patients. Conditional Tsc1 knockout
mice were generated by crossing the RTsc1fl/mut and RTsc1fl/wt
(wt, wild-type) mice with Emx1Cre mice (crossed mice abbrevi-
ated). EMX1 is expressed by embryonic day (E) 9.5 in a subpop-
ulation of dorsal telencephalic radial glia that generate corticalNeuron 84, 78–91, October 1, 2014 ª2014 Elsevier Inc. 79
Figure 2. Tsc1 Deletion In Vivo and Rheb
Hyperactivation In Vitro Increased FLNA
Protein Expression
(A) Images of P14 RTsc1cHet and RTsc1cKO mice
(for R26R/Emx1Cre/Tsc1fl/wt or Tsc1fl/mut).
(B) qRT-PCR Flna/Gapdh transcript levels in the
cortex of RTsc1cHet and RTsc1cKO mice.
(C) Diagram illustrating TSC-mTORC1 pathway.
(D and E) Immunoblots for FLNA, pFLNA, FLNB,
and various proteins in the TSC-mTORC1
pathway and their phosphorylated forms from P7
cortex or P14 OB (D, red) of RTsc1cHet and
RTsc1cKO mice and from Neuro2a (N2a) cells (E,
gray).
(F) Normalized percent changes for pS6/S6,
FLNA/total protein (Tot Prot), and pFLNA/FLNA.
(G) Immunoblots from human cortical tissue from
control and TSC patients. Control and TSC sam-
ples were alternated and probed on the same
membrane without specific order.
(H) Plot of FLNA/Tot Prot versus TSC1/Tot Prot
from control (black) and TSC patients (gray).
(I) Normalized % changes for FLNA/Tot Prot.
Statistical analysis: Student’s t test in (B) and (I)
and one-way ANOVA in (F). *p < 0.05; **p < 0.01;
***p < 0.001; NS, not significant. Error bars corre-
spond to SEM.
See also Figure S1 and Tables S1 and S2.
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2002). Thus, crossing RTsc1fl/mut with Emx1Cre generates a con-
ditional Tsc1 knockout (RTsc1cKO), in which Emx1-dependent
Cre expression results in Tsc1 loss of heterozygosity (Tsc1null)
in cortical astrocytes, cortical neurons, and OB neurons. For
controls, we used conditional Tsc1 heterozygote (RTsc1cHet)
littermates, in which Emx1-driven Cre expression generates
Tsc1 heterozygous cells (Tsc1het). As previously reported, Cre
recombination led to tdTomato expression and enlarged
cortices in RTsc1cKO mice compared to RTsc1cHet littermates
(Carson et al., 2012; Magri et al., 2011) (Figure 2A).80 Neuron 84, 78–91, October 1, 2014 ª2014 Elsevier Inc.We first verified that Flna transcript
levels are elevated in RTsc1cKO using
qRT-PCR. Flna mRNA was significantly
increased in P7 RTsc1cKO compared to
RTsc1cHet cortices (by 360%, n = 4
mice, Student’s t test; Figure 2B). Sec-
ond, we verified that Tsc1 deletion in-
creases mTORC1 activity and tested
whether FLNA protein levels were
increased in RTsc1cKOmice.We immuno-
blotted tissue from P7 cortex (n = 4 mice)
and P14 OB (n = 5 mice) and assessed
mTORC1 by p70 S6 kinase 1 phosphory-
lation (pS6K1), a direct target of
mTORC1, and phosphorylated ribosomal
protein S6 (pS6), a target of S6K1. Using
ERK1/2 or amido black (i.e., total protein)
as a loading control, we found that both
the cortex and OB of RTsc1cKO micedisplay significant increases in mTORC1 activity and FLNA
expression without alterations in relative FLNA phosphorylation
(one-way ANOVA with Tukey posttest throughout the article
unless mentioned otherwise; p values are given in figure legends
for Figures 2C, 2D, and 2F). FLNA belongs to a family of actin-
binding proteins, of which only one other member, FLNB, is ex-
pressed in the central nervous system (Takafuta et al., 1998).
FLNB levels were not altered in cortices or OBs of RTsc1cKO
mice (Figures 2D and 2F).
Next, we used an in vitro system to rule out that increased
FLNA is a nonspecific consequence of seizure activity that
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MEK1-Filamin A and Dendritic Hypertrophy in TSCoccurs in RTsc1cKO mice (Magri et al., 2011). Neuro2a cells were
transfected with either a plasmid encoding constitutively active
Rheb (RhebCA), a downstream target of the TSC complex that
activates the mTORC1 pathway, or a control plasmid encoding
green fluorescent protein (GFP) (Figure 2C) (Lafourcade et al.,
2013; Maehama et al., 2008). Immunoblots performed 48 hr
posttransfection revealed that RhebCA transfection leads to a
significant increase in mTORC1 activity as indicated by
increased levels of pS6K1 and pS6 (n = 3 cells each; Figures
2E, 2F, and S1). RhebCA transfection also led to a significant in-
crease in FLNA levels without affecting its degree of phosphory-
lation and did not alter FLNB levels (Figures 2E and 2F). As such,
disruptions of the TSC pathway can lead to elevated FLNA levels
in the absence of seizures.
Finally, we obtained prefrontal cortical tissue from human
male patients with TSC and age-matched male individuals with-
out any known pathology (Table S3). TSC patients displayed
variability in the TSC1 or TSC2 levels (Figures 2G and 2H).
Such variability among TSC patients may be accounted for by
differences in several parameters including (but not limited to)
the ages of the patients, the degree of seizure activity and drug
treatment, the type of mutation, and the degree of gliosis.
Despite the variability, four out of five TSC patients displayed
FLNA levels above those of control patients (Figures 2G and
2H) and contributed to a significant net increase in FLNA levels
compared to control patients (p < 0.001, Student’s t test; Fig-
ure 2I). Collectively, these data show that FLNA gene expression
and protein levels are increased in cells with decreased TSC
function in mouse models and humans, thus warranting us to
examine the role of FLNA in dendritic development and alter-
ations in TSC.
An Optimal FLNA Level of FLNA Expression Is Required
for Proper Dendritic Morphogenesis
To investigate whether FLNA is a physiologic regulator of den-
dritic morphogenesis in vivo, we used neonatal electroporation
to manipulate FLNA levels in developing neurons (see Figure 1A
for diagram). FLNA and control plasmids were electroporated
into wild-type SVZ cells of P0 wild-type mice using the method
outlined in Figure 1A. During division, electroporated neural pro-
genitors pass their exogenous plasmids on to neuroblasts, which
migrate to and integrate into the OB. By 2 weeks, these neuro-
blasts differentiate into GABAergic interneurons with both an
apical and a basal dendrite. We assessed the complexity and
length of the basal dendrites of transfected neurons in vivo at
14 and 28 days postelectroporation by Sholl analysis of coronal
sections from littermate mice (Figure 3A).
To evaluate the effect of FLNA overexpression, we used a
plasmid encoding FLNA followed by GFP driven by an internal
ribosomal entry site (pCAG-FLNA) and a plasmid encoding
GFP alone (pCAG-GFP) as a control. pCAG-FLNA was validated
by transfecting Neuro2a cells (Figure 3B). To determine whether
pCAG-FLNA was sufficient to increase FLNA levels in neurons,
we electroporated pCAG-FLNA or pCAG-GFP in vivo into SVZ
cells at P0 and cultured transfectedOBneurons 7 days postelec-
troporation. Transfected neurons were visualized by cotrans-
fecting with a plasmid encoding tdTomato (pCAG-tdTomato) in
addition to pCAG-FLNA or pCAG-GFP because the GFP fluores-cence in pCAG-FLNA vector was faint. Because electroporation
only transfects a subset of cells, the cultures contained a mix of
tdTomato+/FLNA+ neurons or tdTomato+/GFP+ neurons with
nontransfected neurons (Figure S2). tdTomato-expressing neu-
rons transfected with the pCAG-FLNA displayed increased
FLNA immunostaining compared to surrounding tdTomato-
negative cells (Figure S2A).
Having validated the pCAG-FLNA plasmid, we tested whether
neuronal FLNA overexpression alters dendritic development
in vivo. Sholl analysis revealed that FLNA overexpression signifi-
cantly alters the basal dendrite by increasingdendritic complexity,
total dendritic length, and the length of the longest dendrite (i.e.,
maximum length) at P14 (two-way repeated-measures ANOVA
with post hoc Bonferroni test, n = 28 neurons, 4 mice each; Fig-
ures 3C–3G). At P28, FLNA-overexpressing neurons displayed a
persistent increase in dendritic complexity and a concomitant in-
crease in total dendritic length; however, themaximum lengthwas
similar to that of controls (n = 24 neurons, 4 mice each; Figures
3C–3G).
We next evaluated the consequence of decreasing FLNA
levels on dendritic development. To do so, we utilized a GFP-ex-
pressing plasmid that also encodes a short hairpin RNA (shRNA)
directed against either FLNA (shFLNA) or luciferase (shLuc, con-
trol). In Neuro2a cells, shFLNA significantly decreased FLNA
protein levels relative to shLuc (n = 3 cells; Figure 3H). Similarly,
newborn neurons cultured 7 days after in vivo coelectroporation
of shFLNA and pCAG-tdTomato displayed decreased FLNA
expression compared to surrounding nontransfected neurons
(Figure S2B). Unexpectedly, shFLNA-electroporated neurons
also displayed increased dendritic complexity at P14 in vivo
compared to shLuc-transfected neurons (n = 50 neurons each,
8 mice each; Figures 3I and 3J). The increased dendritic
complexity was accompanied by significantly increased total
and maximum dendritic length (Figure 3K). This effect was un-
likely to be due to an off-target effect of shFLNA, because it
was prevented by cotransfection with an shFLNA-resistant hu-
man FLNA-encoding plasmid (n = 35 neurons each, 6 mice
each; Figures 3L–3O).
Collectively, thesedata show that both elevated and decreased
FLNAexpression result in increaseddendritic complexity ofwild--
type newborn neurons. This suggests that an optimal level of
FLNA is required for proper dendritic morphogenesis.
Decreasing FLNA Levels Prevents Increased Dendritic
Complexity in Tsc1null Neurons
FLNA overexpression is sufficient to increase dendritic com-
plexity in wild-type neurons, and Tsc1null neurons exhibit more
complex dendritic arborization in the context of elevated FLNA
expression. Therefore, we examined whether decreasing FLNA
levels in Tsc1null neurons is sufficient to prevent dendritic over-
growth. In order to do so, we coexpressed shFLNA and a Cre-
encoding plasmid in RTsc1fl/mut and RTsc1fl/wt neurons. First,
we ensured that shFLNA normalized FLNA levels in Tsc1null neu-
rons by nucleofecting RTsc1fl/mut and RTsc1fl/wt neurons with
Cre and shFLNA or shLuc (Figure 4A). Using this approach,
>70% of the neurons were transfected as visually assessed us-
ing the coexpression of tdTomato (data not shown). After 7 days
in vitro, to allow for loss of TSC1 (Feliciano et al., 2011), weNeuron 84, 78–91, October 1, 2014 ª2014 Elsevier Inc. 81
Figure 3. Over- and Underexpression of FLNA Increases Dendritic Complexity of Newborn Neurons
(A) Image and reconstruction of the basal dendrite of an OB granule cell expressing tdTomato with superimposed concentric circles for Sholl analysis.
(B) Immunoblots for FLNA and GAPDH from Neuro2a cells transfected with pCAG-GFP or pCAG-FLNA.
(C and D) Reconstructions of OB tdTomato+ neurons expressing GFP or FLNA plasmid at P14 (C) and P28 (D).
(E) Number of crossings as a function of distance for the basal dendrites of tdTomato+ neurons at P14 (blue) and P28 (black) and transfected with pCAG-GFP
(open) or pCAG-FLNA (filled). The differences marked with the bar and three asterisks are between the two plasmid conditions at each age.
(F and G) Total dendritic length (F) and maximum length (G) corresponding for the age and conditions shown in (E).
(H) Left: immunoblots for FLNA and GAPDH from Neuro2a cells transfected with shRNA against luciferase (shLuc) or FLNA (shFLNA). Right: quantification of the
blots.
(I) Reconstructions of P14 OB tdTomato+ neurons expressing shLuc or shFLNA.
(J) Number of crossings as a function of distance for the basal dendrites of tdTomato+ neurons at P14 transfected with shLuc (open) or shFLNA (filled).
(legend continued on next page)
Neuron
MEK1-Filamin A and Dendritic Hypertrophy in TSC
82 Neuron 84, 78–91, October 1, 2014 ª2014 Elsevier Inc.
Neuron
MEK1-Filamin A and Dendritic Hypertrophy in TSCimmunoblotted for pS6, S6, FLNA, and ERK1/2 levels. As ex-
pected, Tsc1null neurons displayed significantly increased
FLNA and pS6 levels (Figures 4B and 4C; n = 3 mice each).
Notably, shFLNA decreased FLNA levels in Tsc1null neurons
from 215% to 130% of that of Tsc1het (Figures 4B and 4C).
We then askedwhether decreasing FLNA using shFLNA is suf-
ficient to prevent dendritic dysmorphogenesis of Tsc1null neu-
rons in vivo. Tsc1null neurons were generated in the OB of
Tsc1fl/mut mice by neonatal electroporation of a Cre-encoding
plasmid. At P14 and P28, the dendritic trees of shFLNA-express-
ing Tsc1null neurons were compared to those of Tsc1null and
Tsc1het neurons transfected with the control shLuc plasmid. As
previously reported (Feliciano et al., 2012), Tsc1null neurons in
the OB displayed increased dendritic complexity compared to
Tsc1het neurons (n = 34 neurons each, 4 mice each; Figures 4D
and 4E). Analysis at P14 showed that knocking down FLNA in
Tsc1null neurons significantly reduced their dendritic complexity
and total dendritic length, normalizing them to those of Tsc1het
neurons (n = 34 neurons each, 4 mice each; Figures 4D–4G).
At P28, Tsc1null neurons transfected with shFLNA also displayed
a significant decrease in dendritic complexity and total dendritic
length; however, they were not normalized when compared to
Tsc1het dendrites (n = 32 neurons each, 4 mice each; Figures
S3A and S3B). This is likely due to the progressive dilution of
the shFLNA plasmid in later born Tsc1null neurons subsequent
to multiple rounds of neural progenitor division (Lacar et al.,
2010). We also found that knocking down FLNA in Tsc1het neu-
rons likewise reduced their dendritic complexity and total den-
dritic length (n = 34 neurons each, 4 mice; Figures S3C–S3E).
Reducing FLNA Levels in Tsc1null Neurons Normalizes
Synaptic Event Frequency
Abnormal dendritic patterning should alter network integration
and synaptic activity. In order to evaluate the physiological con-
sequences of altered dendritic complexity, we obtained patch
clamp recordings of neurons between P21 and P25. We found
that Tsc1het and Tsc1null neurons with shLuc or shFLNA dis-
played current-induced action potentials (Figure 5A). Tsc1null
neurons (with shLuc) displayed significantly hyperpolarized
resting membrane potentials (76 versus 68 mV in Tsc1het
neurons) and decreased input resistance (187 versus 414 MU
in Tsc1het neurons, i.e., increased cell conductance) compared
to Tsc1het neurons (n = 6 Tsc1het and 6 Tsc1null neurons; Figures
5B and 5C). In addition, Tsc1null neurons displayed a significantly
increased frequency of miniature synaptic currents (in the pres-
ence of 1 mM tetrodotoxin) compared to Tsc1het neurons (1.7 Hz
versus 0.9 Hz in Tsc1het neurons; Figures 5D and 5E). This finding
is consistent with an increased total dendritic length providing
more area for synaptic contacts. Notably, knocking down(K) Total dendritic length of shLuc- and shFLNA-expressing neurons.
(L) Immunoblots for FLNA and GAPDH from Neuro2a cells transfected with GFP
(M) Reconstructions of P14 OB tdTomato+ neurons expressing shLuc + GFP, sh
(N) Number of crossings as a function of distance for the basal dendrites of P14 t
two top curves. The red bar and three asterisks indicate statistical analysis betw
(O) Total dendritic length of neurons transfected with the vectors indicated in the
Statistical analyses: Student’s t test for (H) and (K), one-way ANOVA for (F), (G), a
for Sholl data. *p < 0.05; **p < 0.01; ***p < 0.001; NS, not significant. Immunoblo
See also Figure S2 and Tables S3 and S4.FLNA normalized the frequency of synaptic inputs consistent
with its normalization of dendritic morphology and length. How-
ever, it did not prevent the changes in resting membrane poten-
tials or cell conductance (n = 7 Tsc1null neurons with shFLNA;
Figures 5B, 5C, and 5E).
Collectively, these data suggest that FLNA contributes to an
increase in dendritic complexity and total length, and to an asso-
ciated increase in synaptic input density in Tsc1null neurons.
Normalizing FLNA levels in Tsc1null neurons is sufficient to pre-
vent these dendritic and synaptic anomalies.
Hyperactive MEK1/2, Not mTORC1, Is Responsible for
Increased FLNA Downstream of TSC-Rheb
Because the mTORC1 pathway is the canonical pathway
increased in TSC, we examined whether elevated FLNA levels
following TSC1 loss are mTORC1 dependent. RTsc1cKO mice
were treated with the mTORC1 blocker, rapamycin at a dose of
0.5 mg/kg (four injections every other day from P7 to P14). Rapa-
mycin significantly reduced mTORC1 activity in OB tissue con-
taining Tsc1null cells, as indicated by reducedpS6 levels; however,
rapamycin had no effect on FLNA levels (n = 3 mice each; Figures
6A and 6B). FLNA levels were similarly unchanged in rapamycin-
treated and RTsc1cHet mice, despite significantly reduced pS6.
Because in vivo treatments can be associated with variable
drug titers, we replicated our in vivo mTOR inhibitor findings in
an in vitro system. Once again, Neuro2a cells transfected with
RhebCA displayed increased FLNA expression (Figures 6C and
6D; see Figure 2). In these cells, elevated pS6 was significantly
reduced by the mTORC1 inhibitor rapamycin and the mTOR ki-
nase inhibitor Torin 1 (Figures 6C and 6D). We tested Torin 1
because it inhibits mTOR kinase activity directly, thereby in-
hibiting both mTORC1 and mTORC2. Torin 1 inhibits mTOR ac-
tivity more uniformly, whereby rapamycin preferentially blocks
mTOR activity toward S6K1 (Choo et al., 2008; Thoreen et al.,
2009). Despite reducing mTOR activity, neither rapamycin nor
Torin 1 significantly reduced FLNA levels in RhebCA-transfected
Neuro2a cells (Figures 6C and 6D). These data suggest that both
Tsc1 deletion and Rheb hyperactivity increase FLNA expression
in an mTOR-insensitive manner.
Although the mTORC1 pathway is the best studied pathway in
TSC, the MEK-ERK1/2 pathway is another critical regulator of
cell growth and development that has been shown to be hyperac-
tive in TSC (Che´vere-Torres et al., 2012;Magri et al., 2011;Maldo-
nadoetal., 2003). Inaddition, FLNA transcription ispredicted tobe
under the regulation of the MEK-ERK1/2 pathway (D’Addario
etal., 2002,2006;TanandKhachigian,2009).Therefore,we tested
whether elevated FLNA in RTsc1cKO mice is due to hyperactive
MEK-ERK1/2 pathway activity. Consistent with previous findings,
we found that ERK1/2 activity is significantly increased inor human FLNA (hFLNA).
FLNA + GFP (both red), or shFLNA + hFLNA (black).
dTomato+ neurons. The green arrow indicates statistical analysis between the
een the red curves.
key in (N).
nd (O), and two-way repeated-measures ANOVA with post hoc Bonferroni test
ts in each panel are from the same membrane. Error bars correspond to SEM.
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Figure 4. Knockdown of FLNA Prevents
Increased Dendritic Complexity in Newborn
Tsc1null Neurons
(A) Diagram detailing the mice and vectors used
for electroporation. Electroporation of a Cre-en-
coding vector in dissociated neurons (in B) or
neural progenitor cells in vivo (in D to G) from
RTsc1fl/wt or RTsc1fl/mut mice results in tdTomato
expression (R26R-tdTomato mice) and Tsc1
excision.
(B and C) Western blots (B) for pS6, S6, FLNA, and
ERK1/2 and bar graphs of FLNA/ERKs signals (C)
from cortical neurons under conditions shown
above the blots. Neurons were isolated at P0 from
RTsc1fl/wt and RTsc1fl/mut mice and nucleofected
with Cre and either shLuc or shFLNA.
(D) Reconstructions of the basal dendrites of P14
Tsc1het and Tsc1null neurons transfected with
shLuc or shFLNA (red).
(E) Sholl analysis for neurons whose examples are
shown in (D). The statistical analysis (***) refers to
Tsc1het compared to Tsc1null (both with shLuc) and
Tsc1null + shLuc compared to Tsc1null + shFLNA.
(F and G) Total dendritic length (TDL, E) and
maximum length (F) of Tsc1het and Tsc1null neu-
rons with or without shFLNA.
*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001;
NS, not significant. Error bars correspond to SEM.
See also Figure S3 and Table S1 and S4.
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Figures 6A and 6B). In vitro,RhebCA also increasedMEK1-ERK1/2
activity as assessedwithpERK1/2 (Figures 6Cand6D). Therefore,
we hypothesized that hyperactive MEK-ERK1/2 pathway activity,
not mTORC1 activity, is responsible for elevated FLNA down-
stream of Tsc1 deletion and RhebCA overexpression.
To test this, we first treated RhebCA-transfected Neuro2a cells
with two MEK1 inhibitors, PD0325901 and U0126. Control cells84 Neuron 84, 78–91, October 1, 2014 ª2014 Elsevier Inc.were treated with either vehicle or U0124,
the inactive form of U0126. The concen-
tration of MEK1 inhibitors used in these
experiments was determined by testing
a range of concentrations and immuno-
blotting for pERK1/2 (n = 3 cells; Fig-
ure S4). Consistent with our hypothesis,
both U0126 and PD0325901 significantly
reduced MEK-ERK1/2 pathway activity
aswell asFLNA levels (Figures6Cand6D).
Critically, neither MEK1 inhibitor altered
mTORC1 activity, as demonstrated by
persistently elevated pS6 levels (Figures
6C and 6D). Thus, MEK1 inhibition is suffi-
cient to reduce FLNA levels in the context
of elevated mTORC1 signaling.
Collectively, these data suggest that,
although mTOR and MEK-ERK1/2 activ-
ities are increased in parallel subsequent
to Tsc1 deletion or Rheb hyperactivation,
elevated FLNA expression is due to
elevatedMEK-ERK1/2 and notmTOR ac-tivity (model in Figure 6E). We next sought to establish a causal
relationship between MEK-ERK1/2-FLNA and the dendritic ab-
normalities in the context of TSC.
Hyperactive MEK-ERK1/2 Signaling Increases Dendritic
Complexity via FLNA in Tsc1null Neurons
First, we assessed whether increasing MEK-ERK1/2 activity in
wild-type neurons is sufficient to recapitulate the dendritic
Figure 5. Knockdown of FLNA Normalizes Synaptic Frequency in Newborn Tsc1null Neurons
(A) Representative examples of current-induced action potentials in tdTomato+ granule neurons in acute OB slices.
(B) Mean resting membrane potentials from neurons whose examples of action potentials are shown in (A).
(C) Mean input resistance from Tsc1het (n = 6) and Tsc1null neurons with shLuc (n = 5) or shFLNA neurons (n = 7).
(D) Representative examples of miniature synaptic currents recorded in the presence of tetrodotoxin.
(E) Frequency of miniature synaptic currents of tdTomato+ neurons.
Statistic: one-way ANOVA; *p < 0.05; **p < 0.01; ***p < 0.001; NS, not significant. Scale bars, 40 mV/100 ms in (A) and 40 pA/600 ms in (C). Error bars correspond
to SEM.
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MEK-ERK1/2 dendritic defects require upregulation of FLNA
expression (Figure 7A for a diagram of vectors used). To increase
ERK1/2 activity, we obtained a constitutively active MEK1
(MEK1CA, DN-S222D mutant; Mansour et al., 1994). In Neuro2a
cells, MEK1CA led to increased MEK-ERK1/2 activity and FLNA
expression (Figure 7B). In cultured wild-type cortical neurons,
MEK1CA expression led to a significant increase in MEK-ERK1/
2 activity and FLNA transcription, which was measured using a
luciferase reporter under a mouse Flna reporter (n = 6 sets of
culture; Figures 7C and 7D, increase in MEK-ERK1/2 activity
not shown). We therefore assessed the effect of hyperactive
MEK1/2 activity on dendritogenesis in vivo by electroporating
the MEK1CA-encoding plasmid into neonatal progenitor cells as
described in Figure 1. MEK1CA expression in vivo led to a sig-
nificant increase in the dendritic complexity and total dendritic
length of newborn neurons at both P14 (n = 39 neurons per
condition, 4 mice each; Figures 7E–7G) and P28 (n = 4 mice;
data not shown). Notably, knocking down FLNA inwild-type neu-
rons expressing MEK1CA was sufficient to normalize dendritic
morphology (Figures 7E–7G). These data suggest that the MEK-
ERK1/2 pathway can regulate dendritic patterning via FLNA.
These results suggest that hyperactive MEK-ERK1/2 drives
pathologic FLNA expression and contributes to dendritic dys-
morphogenesis in TSC. To address this possibility, we examined
whether hyperactive MEK-ERK1/2 activity underlies abnormal
dendritic morphology in Tsc1null neurons, using a dominant-
negative MEK1 vector (MEK1DN, K97M mutant; Mansour et al.,
1994). In Neuro2a cells, transfection of MEK1DN decreased
pERK1/2 and FLNA levels (Figure 7B). In vivo, coelectroporation
of MEK1DN and Cre prevented the increases in dendritic
complexity and length of Tsc1null cells seen in control (GFP) elec-
troporated Tsc1mull cells when analyzed at both P14 (n = 24–27
neurons per condition, 4 mice each; Figures 7H–7J) and P28
(n = 31 neurons per condition, 4mice; Figures S5A–S5C). Collec-
tively, these data provide strong evidence that MEK-ERK1/2contributes to dendritic abnormalities in Tsc1null neurons by
increasing FLNA expression.
Pharmacological Inhibition of MEK-ERK1/2 or mTORC1
Activity in Tsc1null Neurons Rescues Dendritic Defects
As we previously showed that mTOR inhibition partially rescues
dendritic hypertrophy (Lafourcade et al., 2013), we wondered
whether reducing MEK1-ERK1/2 activity also recues dendritic
defects of Tsc1null cells. Because coincident electroporation of
MEKDN and Cre does not allow use to distinguish rescue of the
dendritic phenotype from prevention of the phenotype, we
used a pharmacological approach to inhibit MEK1-ERK1/2 activ-
ity after the establishment of dendritic abnormalities. Specif-
ically, we tested whether the MEK1/2 blocker PD0325901 can
rescue FLNA levels and dendritic defects in Tsc1null neurons.
PD0325901 used at 1 mg/kg in vivo significantly decreased
ERK1/2 activity in the OB of Tsc1fl/mut mice treated from P14 to
P28 (n = 4 mice; Figures S6A and S6B).
To test the ability of PD0325901 to decrease FLNA levels in
Tsc1null neurons, dissociated neurons from RTsc1fl/mut and
RTsc1fl/wt mice were transfected with a Cre-encoding plasmid
and cultured for 7 days in the presence of PD0325901 (2 mM;
Figure 8A). PD0325901 significantly decreased FLNA levels,
albeit not to the levels seen in Tsc1het neurons (n = 3 sets of cul-
tures; Figures 8B and 8C). Notably, in vivo treatment with
PD0325901 (1 mg/kg) from P14 to P28 significantly decreased
the dendritic complexity and total dendritic length of Tsc1null
neurons (Figures 8A, 8D, and 8E). A similar treatment with rapa-
mycin (0.5 mg/kg, every other day), which decreased mTORC1
activity (Figure S6C), also significantly decreased dendritic
complexity and normalized dendritic length of Tsc1null neurons
compared to Tsc1het neurons (Figures 8D–8F). These data sug-
gest that increased mTORC1 and MEK-ERK1/2 signaling inde-
pendently contributes to dendritic defects in Tsc1null neurons.
Based on our data, blocking either pathway is sufficient to
significantly prevent the dendritic defects.Neuron 84, 78–91, October 1, 2014 ª2014 Elsevier Inc. 85
Figure 6. FLNA Overexpression Is Sensitive to MEK-ERK1/2 Blockade but Insensitive to mTOR Blockade
(A) Immunoblots for FLNA, S6K1, S6, ERK1/2, and their respective phosphorylated forms from P14 OB of RTsc1cHet and RTsc1cKO mice (n = 3 mice each).
(B) Normalized percent changes for pS6/S6, FLNA/ERK1/2, and pERK1/2/ERK1/2 in RTsc1cHet (black) and RTsc1cKO mice (red) with or without rapamycin
treatment in vivo.
(C) Immunoblots for FLNA, S6, ERK1/2, and their phosphorylated forms in GFP- (control) and RhebCA-transfected Neuro2a cells treated with vehicle, mTOR
(rapamycin [RAPA] and Torin 1) blockers, or MEK-ERK1/2 blockers, PD0325901 (PD, 2 mM), and U0126 (20 mM, n = 3 sets of Neuro2a cells). U0124 (20 mM) is the
inactive form of U0126.
(D) Normalized percent changes for pS6/S6, FLNA/ERK, and pERK/ERK in GFP- and RhebCA-transfected cells.
(E) A simplified model of TSC-mTOR-MEK-FLNA and the sites of actions of drugs and plasmids used for data acquisition. Dotted lines indicate that the
mechanisms linking Rheb to MEK1/2 and FLNA remain unknown.
*p < 0.05; **p < 0.01; ***p < 0.001; NS, not significant. Error bars correspond to SEM. See also Figure S4 and Tables S1 and S4.
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Here we report that FLNA regulates dendritic morphogenesis.
Moreover, FLNA overexpression underlies pathologic morpho-
logical and physiological defects in a mouse model of the hu-
man disorder TSC. We found that increased FLNA levels in
our TSC models are MEK-ERK1/2 dependent, and as such,
reducing MEK-ERK1/2 signaling was sufficient to significantly
rescue the dendritic defects. Additionally, early interventions
that decrease FLNA levels in either Tsc1null or hyperactive
MEK-ERK1/2 conditions are sufficient to prevent abnormal den-
dritic development.
Based on our findings, it is clear that conditions that push FLNA
expression out of a narrow physiologic range promote abnormal
dendritic patterning. To our surprise, both increasing and86 Neuron 84, 78–91, October 1, 2014 ª2014 Elsevier Inc.decreasing FLNA levels leads to increased dendritic complexity
in newborn neurons. Although unexpected, this finding is not un-
reasonable, considering that both high and low levels of FLNA
expression impair cell migration, implying a bell-shaped function
for optimal FLNA expression (Cunningham et al., 1992; Sarkisian
et al., 2008). Similar to cellmigration, deviation fromoptimal FLNA
expression in either direction results in hypertrophic dendrites.
How both under- and overexpression of FLNA produce the
same phenotype is not clear; however, it is notable that FLNA
has multiple physiologic functions. Not only is FLNA involved in
cytoskeletal reorganization by binding to and crosslinking actin,
but it also serves as a signaling and scaffolding protein that links
the cytoskeleton to membrane and signaling molecules (Feng
and Walsh, 2004; Razinia et al., 2012; Stossel et al., 2001). It is
possible that these distinct FLNA functions independently
Figure 7. Increased MEK-ERK1/2 Activity in Tsc1null Neurons Promotes Dendritic Abnormalities through FLNA
(A) A simplified model of TSC-mTOR-MEK-FLNA and the sites of actions of tested drugs and plasmids.
(B) Immunoblots from Neuro2a cells transfected with GFP, MEK1CA, or MEK1DN.
(C and D) Diagram of luciferase vectors (C) and normalized ratio of Gaussia luciferase driven by FLNA promoter activity over Renilla luciferase driven by SV40
promoter activity in cultured cortical neurons transfected with GFP or MEK1CA and appropriate luciferase vectors.
(E) Reconstructions of the basal dendrites of P14 tdTomato+ OB neurons transfected with either GFP + shLuc, MEK1CA + shLuc (green), or MEK1CA + shFLNA
(red).
(F) Sholl analysis for neurons whose examples are shown in (E). The statistical analysis (indicated by two green asterisks) refers to MEK1CA neurons with shLuc or
shFLNA.
(G) Total dendritic length (TDL) from the Sholl data in (F).
(H) Reconstructions of the basal dendrites of Tsc1het transfected with GFP and Tsc1null neurons transfected with either GFP or MEK1DN (red).
(I) Sholl analysis for neurons whose examples are shown in (H). The statistical analysis (two red asterisks) refers to Tsc1null + GFP compared to Tsc1null + MEK1DN.
(J) Total dendritic length (TDL) from Sholl data in (I). Student’s t test or one-way ANOVA and two-way repeated-measures ANOVA with post hoc Bonferroni test
used. **p < 0.01; ***p < 0.001. Error bars correspond to SEM.
See also Figure S5 and Tables S1 and S4.
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MEK1-Filamin A and Dendritic Hypertrophy in TSCcontribute to dendritogenesis in differing ways. Understanding
specifically how both under- or overexpression of FLNA lead to
dendritic hypertrophy is the focus of ongoing study.Nonetheless, overexpression of FLNA in Tsc1null neurons con-
tributes to increased dendritic complexity, as indicated by the
fact that normalizing FLNA levels rescues dendritic complexity.Neuron 84, 78–91, October 1, 2014 ª2014 Elsevier Inc. 87
Figure 8. Pharmacological Inhibition of
MEK-ERK1/2 or mTORC1 Activity in Tsc1null
Neurons Rescues Dendritic Defects
(A) Experimental design for in vitro (B and C) and
in vivo (D and E).
(B) Western blots from Tsc1het neurons treated
with vehicle (Veh) and Tsc1null neurons treated
with vehicle or PD0325901 (PD).
(C) Bar graphs of FLNA signals from data in (B).
(D and E) Representative images of basal den-
drites (D) and Sholl analysis (E) for Tsc1het neurons
in mice treated with vehicle (Veh) and Tsc1null
neurons in mice treated with vehicle, PD, or ra-
pamycin (RAPA). The statistical analysis ( indi-
cated by three asterisks in red and blue) refers to
Tsc1null neurons treated with PD and RAPA,
respectively.
(F) Total dendritic length (TDL) from the Sholl data
in (E). One-way ANOVA and two-way repeated-
measures ANOVA with post hoc Bonferroni test
were used. *p < 0.05; **p < 0.01; ***p < 0.001;
****p < 0.0001. Error bars correspond to SEM.
See also Figure S6 and Table S1.
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MEK1-Filamin A and Dendritic Hypertrophy in TSCTsc1 null cells are enlarged (Feliciano et al., 2013a), suggesting
that elevated FLNA could be secondary to a general upregulation
of cytoskeletal proteins; however, we found that this is not the
case, as FLNB levels were unaltered in Tsc1null cells. Cellular
enlargement in TSC is due to hyperactive mTORC1, which pro-
motes both cellular and dendritic hypertrophy (Feliciano et al.,
2013a). Therefore, we expected elevated FLNA to be secondary
to mTORC1 hyperactivity.
Counter to our expectations, we found strong evidence that,
although Tsc1 deletion in vivo and constitutively active Rheb
expression in vitro lead to hyperactive mTORC1 and dendritic
hypertrophy, elevated FLNA expression is not downstream of
mTORC1. Instead, pathologic FLNA expression in our model
of TSC is due to hyperactive MEK-ERK1/2 signaling, and block-
ing the MEK-ERK1/2 pathway is sufficient to rescue dendritic
defects. Speculation about how Rheb and the upstream TSC
complex signal to MEK-ERK1/2 to regulate FLNA expression is
difficult, given that Rheb signaling outside of mTORC1 is under-
studied (Jaeschke et al., 2002; Neuman and Henske, 2011).
Conjecture about how MEK-ERK1/2 regulates FLNA expres-
sion, however, is more feasible, given that the transcriptional
activator serum response factor (SRF) is regulated by ERK
(D’Addario et al., 2002, 2006; Tan and Khachigian, 2009). SRF
is predicted to regulate FLNA expression and indeed, knocking
down SRF in Neuro2a cells decreases FLNA expression (L.Z.
and A.B., unpublished data). As such, MEK-ERK1/2 hyperactiv-
ity in the setting of TSC may promote dendritic hypertrophy via
SRF-dependent transcriptional upregulation of the FLNA gene.
This is consistent with studies showing that MEK-ERK1/2 activ-
ity regulates neurite growth in many cell types (e.g., PC12 cells)
and dendritic growth in neurons (Collo et al., 2008; Guo et al.,
2012; Ha and Redmond, 2008; Kim et al., 2004; Xu et al.,
2014). Whatever the mechanism, our data showing that MEK1
overexpression leads to FLNA-dependent dendritic hypertrophy
in wild-type cells reinforces the finding that reduction of either
MEK1 activity (using a dominant-negative vector) or FLNA88 Neuron 84, 78–91, October 1, 2014 ª2014 Elsevier Inc.expression (using shRNA) normalizes dendritic hypertrophy
in TSC.
Normalizing dendrites in TSC is not purely cosmetic. Consis-
tent with our previous report in which we overexpressed constitu-
tively active Rheb (Lafourcade et al., 2013), we found that Tsc1null
neurons display a significant increase in the frequency of minia-
ture synaptic currents. Normalizing dendritic morphology by
decreasing FLNA levels in Tsc1null neurons also restored a normal
frequency of synaptic currents. This rescue could not be general-
ized to all physiologic defects, as Tsc1null neurons also displayed
a relatively depolarized resting membrane potential and a de-
creased input resistance that were not normalized by FLNA
knockdown. These data indicate that electrophysiological de-
fects in TSC are multifactorial.
Finally, it is important to note that we have previously shown
that mTORC1 hyperactivity promotes dendritic hypertrophy,
and we replicate that finding here. Indeed, we and others have
shown that rapamycin reduces hypertrophic dendrites in con-
ditions of hyperactive Rheb or PI3K-AKT, both of which are as-
sociated with hyperactive mTORC1 (Feliciano et al., 2013a;
Jaworski et al., 2005; Lafourcade et al., 2013). That the reduction
of mTORC1 or MEK1 activity in Tsc1null cells is sufficient to pro-
vide for a dendritic rescuewithout altering the activity of the other
signaling pathway indicates that both mTORC1 and MEK1-
ERK1/2 pathways contribute to dendritic hypertrophy in the
context of TSC.
Thus, our study provides for the possibility that that inhibit-
ing MEK-ERK1/2 activity or normalizing FLNA in TSC may be
of therapeutic value. It also suggests that normalizing FLNA
may be of benefit in other disorders where the MEK1-ERK1/
2 pathway is hyperactive, such as autism spectrum disorders
(Cusco´ et al., 2009; Levitt and Campbell, 2009; Samuels
et al., 2009). Although the study of TSC has historically
been mTOR-centric, this work provides a motivation for
exploration of additional and complementary approaches to
treating TSC.
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Animals and Genotyping
Research protocols were approved by the Yale University Institutional Animal
Care and Use Committee. Experiments were performed on wild-type CD1 and
the following lines of transgenic mice of either gender: R26RtdTomato/Tsc1fl/mut
mice (abbreviated RTsc1fl/mut) and RTsc1fl/wt mice; R26RtdTomato/Emx1Cre/
Tsc1fl/mut mice (abbreviated RTsc1cKO); and RTsc1cHet. Breeding strategies
and genotyping are detailed in the Supplemental Information.
Human Samples
Human tissue was obtained from the Eunice Kennedy Shriver National Institute
of Child Health and Human Development Brain and Tissue Bank for Develop-
mental Disorders in accordance with the Yale University human ethical commit-
tee. Tissuewas from theprefrontal cortex ofmale individuals. Patient information
is provided in Table S2. We ran TSC and control samples on the same mem-
brane in a randomized order.
RNA Isolation, Mouse Neurogenesis RT2 Profiler PCR Array, and
qRT-PCR
RNA was extracted using standard Trizol protocol. Complementary DNA
(cDNA) was prepared using the RT2 Nano PreAMP cDNA Synthesis Kit (SA Bio-
sciences). cDNA (12 ml), combined with the FastStart Universal SYBR Green
Master (Roche), was loaded per well on the Mouse Neurogenesis PCR Array
(384-well plate; SA Biosciences). For qRT-PCR, 2.12 mg of RNA was mixed
with dinucleotide triphosphates, random primers (Invitrogen). cDNA was sub-
jected to PCR with primers to mouse Flna (F, GCACCGCAAGCACAACCA; R,
CACAGCTGTCTACCAGGGC) and Gapdh (F, ACCACCATGGAGAAGGC; R,
GGCATGGACTGTGGTCATGA).
Vectors
Vectors used are provided in Table S3, and additional details are provided in
the Supplemental Information.
Western Blot Analysis from Mice and Neuro2a Cells and Antibodies
The Neuro2a mouse neuroblastoma cells were propagated using standard
protocol and transfected with Polyjet (SignaGen Laboratories) at 80% conflu-
ence. Protein was harvested 48 hr after transfection.
Western blotting protocol is detailed in the Supplemental Information. Quan-
tifications were performed using NIH ImageJ software. Primary antibodies are
listed in Table S4. ERK or total protein (Amido Black) signals were used as
loading controls and gave similar results. For the phosphorylated form of pro-
teins, data were normalized to the total (unphosphorylated) levels from the
same polyvinylidene fluoride membrane. For western blot normalization across
blots (Figure 6C) within a given experiment, a standard sample was run on each
gel (see details in the Supplemental Information).
Drug Treatment
Drug treatment and preparation are detailed in the Supplemental Information.
Rapamycin and PD0325901 were purchased from A.G. Scientific (#R-1018)
and Seleckbio (#PD0325901), respectively. Torin 1 and ERK blockers (U0126
and U0124) were from Tocris.
Neonatal Electroporation
Electroporations were performed as described elsewhere (Lacar et al., 2010,
2012; Platel et al., 2010; Feliciano et al., 2013b) and are detailed in the Supple-
mental Information.
Culture of In Vivo Transfected Neurons and FLNA Immunostaining
Seven days following electroporation, OBswere dissected in ice-cold dissection
medium (Hank’s balanced salt solution with 10mMHEPES). Following standard
dissociationprotocol, cellswere resuspended inminimumessentialmediumsup-
plemented with 0.6% glucose and 5% fetal bovine serum and were plated on
poly-D-lysine-coated coverslips. The medium was changed to neuronal mainte-
nancemedium (neurobasal A mediumwith 13 B27 and 13GlutaMAX-1) 3 hr af-
ter plating and every other day thereafter. Twenty-four hours after plating, FLNA
immunostaining was performed using a standard protocol (Platel et al., 2009).Culture of P0 Cortical Neurons Followed by Nucleofection
The cortex of P0 pups was dissected out to prepare primary neuronal culture
as described earlier. Once in cell suspension, neurons were nucleofected us-
ing the Mouse Neuron Nucleofector Kit VPG-1001 (Lonza) and following the
manufacturer’s instructions. Western blot analysis was performed 7 days
following nucleofection.
Morphometric Analysis
Images of tdTomato+ basal dendrites were acquired in coronal sections using
a Fluoview 1000 confocal microscope and 203 objective. Basal dendrites
were traced with simple neurite tracer software (FIJI and GNU GPL, v3). Sholl
analyses were carried out using the number of intersections in 10-mm-incre-
ment concentric circles as a measure of morphological complexity. z stacks
from three different square fields of view were taken from three different OB
sections. Analysis was performed blindly with more than four animals and
more than 20 cells per condition. Experiments were performed at two time
points to validate that the dendrites did not recover by P28 because of den-
dritic pruning. We showed the P28 data in Figures S1–S6 because, by P28,
the ‘‘rescue’’ effect is underestimated due to dilution of the electroporated
vectors.
OB Acute Slice Preparation
Coronal OB slices (350 mm) were prepared from anesthetized (Isoflurane 5%)
P21–P24 mice using Vibratome 1000. Ice-cold artificial cerebral spinal fluid
(ACSF) containing, in millimolars, 124 NaCl, 3 KCl, 1.25 NaH2PO4, 1 MgSO4,
26 NaHCO3, 10 dextrose, 2 CaCl2, 0.4 ascorbate, 4 Na-lactate, and 2 Na-py-
ruvate (290 mOsm/kg, pH 7.2, equilibrated with 95% O2/5% CO2 ) was used
during both brain dissection and slicing. Brain slices were kept and used for
recordings at 28C in the ACSF mentioned earlier.
Whole-Cell Recording of OB Granule Cells
Fluorescent cells were identified using a 403 water-immersion Olympus
LUMPlanFL/IR objective. Whole-cell recordings were performed with an Axo-
patch 200B amplifier using glass pipettes (4–7 MU) filled with internal solution
consisting of the following (in millimolars): 130 KCl, 10 HEPES, 10 di-tris-phos-
phocreatine, 1 EGTA, 0.1 CaCl2, 1.5 MgCl2, 4 Na2-ATP, and 0.3 Na-GTP.
Liquid junction potential (4 mV) was not corrected. Miniature synaptic cur-
rents were recorded at 70 mV in the presence of 1 mM tetrodotoxin. Data
were analyzed with Clampfit 10 (Molecular Devices).
Luciferase Assay
The standard procedure is detailed in the Supplemental Experimental Proce-
dures and was duplicated for each sample.
Statistics
Data were plotted in Origin 8. Statistical significancewas determined using un-
paired two-tailed Student’s t test or one-way ANOVA with Tukey post hoc
except for Sholl analysis with p < 0.05 for significance for all experiments.
For Sholl analysis, we used two-way repeated-measures ANOVA with post
hoc Bonferroni test for comparison of dendritic crossing. Data are presented
as mean ± SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and four tables and can be found with this article online at http://
dx.doi.org/10.1016/j.neuron.2014.09.009.
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